The generics industry in Canada is anticipated to grow at a CAGR of around 14% during 2009-2013 owing to patent expiry of several blockbuster drugs, says RNCOS in its latest research study.

Noida, UP -- (SBWire) -- 01/13/2011 -- As per our latest research report “Generic Drug Market in Canada”, the Canadian generics industry is anticipated to show healthy growth rates in coming years and is projected to witness a CAGR growth of around 14% during 2009-2013. Future of the industry remains promising owing to higher margins and lower competition in Canada compared to other big markets. We have found that the growth in the generics industry will be mainly driven by ageing population, patent expiry of several blockbuster drugs, and the government support in the form of cost containment. Besides, high participation in industry activities by the market players, higher margins to pharmacists, and effective developmental efforts by provinces will drive the optimistic performance of the industry.

Our research indicates that presently the share of generic drugs in Canada is about one-fourth of the overall pharmaceutical market.

Besides, many foreign firms are looking forward to invest in the Canadian generics industry. Some key therapy areas such as, chronic disease, hypertension, and diabetes represent big opportunity for generic drug manufacturers in Canada. We have also evaluated various factors that will propel the growth of generics market in Canada during the forecast period (2011-2013).

The report "Generic Drug Market in Canada" is a complete source of knowledge and analysis regarding the Canadian generic drugs sector with complete emphasis on data reliability and authentication. The report has covered every important aspect of the generic drug market and elaborated significant proportion of the current market trends along with their future outcome. Sections like, 'generics market performance' and 'regulatory environment' provides an in-depth market analysis and key activities by the government respectively. These sections measure industry in terms of key statistics and current regulatory mechanisms that have a major impact on current revenue patterns and future growth.

The report is an outcome of an in-depth research and prudent analysis of the Canadian generic sector with effective presentation and forecasting in key areas. The forecasting in report relies on suitable methods and techniques that further enhance reliability in future projection. Moreover, the major activities and description of market players have been elucidated in the report.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM598.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.